Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 697.94B | 727.49B | 617.71B | 502.20B | 458.23B | 471.06B |
Gross Profit | 48.90B | 47.58B | 53.33B | 26.42B | 37.23B | 50.04B |
EBITDA | 24.53B | 30.52B | 37.30B | 11.66B | 22.42B | 38.12B |
Net Income | 14.11B | 12.46B | 17.88B | 684.00M | 10.75B | 20.99B |
Balance Sheet | ||||||
Total Assets | 701.87B | 660.13B | 566.03B | 508.18B | 467.36B | 452.25B |
Cash, Cash Equivalents and Short-Term Investments | 51.44B | 57.27B | 60.19B | 50.50B | 44.86B | 59.79B |
Total Debt | 232.04B | 166.47B | 110.32B | 93.69B | 92.56B | 82.21B |
Total Liabilities | 532.42B | 488.00B | 392.97B | 351.23B | 307.58B | 293.85B |
Stockholders Equity | 169.26B | 172.06B | 173.01B | 156.84B | 159.60B | 158.28B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -61.48B | -1.75B | 9.57B | -16.34B | 19.65B |
Operating Cash Flow | 0.00 | -23.33B | 9.14B | 19.69B | -7.69B | 30.69B |
Investing Cash Flow | 0.00 | -23.22B | -6.41B | -11.70B | -11.82B | -12.80B |
Financing Cash Flow | 0.00 | 43.88B | 6.71B | -6.96B | 1.36B | -3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €274.84B | 9.04 | 16.30% | 5.25% | 7.87% | 90.38% | |
75 Outperform | ¥294.86B | 11.45 | 3.02% | 12.29% | 59.92% | ||
75 Outperform | ¥305.71B | 9.94 | 4.79% | ― | ― | ||
71 Outperform | ¥255.13B | 13.43 | 8.49% | 3.04% | 6.31% | 12.97% | |
70 Outperform | ¥191.63B | 10.92 | 4.94% | -8.67% | 40.83% | ||
69 Neutral | ¥268.20B | 21.35 | 7.12% | 2.55% | 17.77% | -29.69% | |
69 Neutral | ¥107.30B | 16.34 | 3.65% | 2.61% | -9.19% |